Bilateral carcinomas of the breast with local recurrence: Analysis of genetic relationship of the tumors

Modern Pathology

Volumn 17, Issue 5, 2004, Pages 597-602

  Regitnig, Peter ^a   Ploner, Ferdinand ^a   Maderbacher, Martina ^a   Lax, Sigurd F ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b General Hospital Graz West   (Austria)

Author keywords

Bilateral breast carcinoma; Clonality; Local recurrence; Loss of heterozygosity; Microsatellite analysis

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER INFILTRATION; CANCER RECURRENCE; CLONAL VARIATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MASTECTOMY; METASTASIS; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 3042843623     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800089     Document Type: Article

References (27)

1. Chen Y, Thompson W, Semenciw R, et al. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:855-861.
2. Noguchi S, Motomura K, Inaji H, et al. Differentiation of primary and secondary breast cancer with clonal analysis. Surgery 1994;115:458-462.
3. Shibata A, Tsai YC, Press MF, et al. Clonal analysis of bilateral breast cancer. Clin Cancer Res 1996;2:743-748.
4. Imyanitov EN, Suspitsin EN, Grigoriev MY, et al. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. Int J Cancer 2002;100:557-564.
5. Kollias J, Ellis IO, Elston CW, et al. Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 2001;25:1117-1124.
6. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410.
7. Tavassoli FA. Pathology of the Breast. 2nd edn. Appleton Lange: Stanford, CT, 1998.
8. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors - International Union Against Cancer (UICC). 6th edn. Wiley-Liss: New York, 2002.
9. Deng G, Lu Y, Zlotnikov G, et al. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-2059.
10. Kerangueven F, Eisinger F, Noguchi T, et al. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 1997;14:339-347.
11. Nagai MA, Yamamoto L, Salaorni S, et al. Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumours. Genes Chromosomes Cancer 1994;11:58-62.
12. Tran Y, Benbatoul K, Gorse K, et al. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene 1998;17:3499-3505.
13. Garcia JM, Silva JM, Dominguez G, et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 1999;57:237-243.
14. Shi W, Zhang X, Pintilie M, et al. Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer 2003;104:195-203.
15. Overgaard J, Yilmaz M, Guldberg P, et al. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer. Acta Oncol 2000;39:327-333.
16. Jones MH, Nakamura Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 1992;5:89-90.
17. Winqvist R, Hampton GM, Mannermaa A, et al. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 1995;55:2660-2664.
18. Eiriksdottir G, Johannesdottir G, Ingvarsson S, et al. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 1998;34:2076-2081.
19. van den Berg J, Johannsson O, Hakansson S, et al. Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 1996;74:1615-1619.
20. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-5063.
21. Catasus L, Machin P, Matias-Guiu X, et al. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol 1998;29:1160-1164.
22. Regitnig P, Moser R, Thalhammer M, et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol 2002;198:190-197.
23. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
24. Lininger RA, Fujii H, Man YG, et al. Comparison of loss of heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol 1998;11:1151-1159.
25. Diaz-Cano SJ, Blanes A, Wolfe HJ. PCR techniques for clonality assays. Diagn Mol Pathol 2001;10:24-33.
26. Pozo-Garcia L, Diaz-Cano SJ. Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together. Am J Pathol 2003;162:353-354.
27. Tang M, Pires Y, Schultz M, et al. Microsatellite analysis of synchronous and metachronous tumors: a tool for double primary tumor and metastasis assessment. Diagn Mol Pathol 2003;12:151-159.